Condition
End Stage Heart Disease
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 1 (1)
P 4 (1)
Trial Status
Completed3
Terminated1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02387112Not ApplicableUnknownPrimary
Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation
NCT01571037Phase 1CompletedPrimary
Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study
NCT03208244Phase 4TerminatedPrimary
DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant
NCT02086305Not ApplicableCompletedPrimary
Transitional Palliative Care in End-stage Heart Failure
NCT02149316Not ApplicableCompleted
Remote Ischemic Preconditioning With Postconditioning in Heart Transplantation Surgery
Showing all 5 trials